<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Mehreen S</submitter><funding>Quaid-i-Azam University</funding><pagination>14717-14729</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC12056728</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>15(19)</volume><pubmed_abstract>Effective α-glucosidase inhibitors are vital for managing type 2 diabetes, emphasizing the need for novel and potent compounds. A series of novel &lt;i>N&lt;/i>-phenoxyethylisatin hydrazones 1(a-l) have been synthesized and characterized by their spectral data, and in the case of 1l by its single crystal X-ray analysis. All the synthesized compounds were &lt;i>in vitro&lt;/i> evaluated for their inhibition potential against the α-glucosidase enzyme. Interestingly, most of these compounds exhibited significant inhibitory activity against the α-glucosidase enzyme, with IC&lt;sub>50&lt;/sub> values ranging from 3.64 ± 0.13 to 94.89 ± 0.64 μM compared to the standard drug, acarbose (IC&lt;sub>50&lt;/sub> = 873.34 ± 1.67 μM). The compound 1e was found to be the most active compound of the series having an IC&lt;sub>50&lt;/s</pubmed_abstract><journal>RSC advances</journal><pubmed_title>Synthesis, structural insights and bio-evaluation of &amp;lt;i&amp;gt;N&amp;lt;/i&amp;gt;-phenoxyethylisatin hydrazones as potent α-glucosidase inhibitors.</pubmed_title><pmcid>PMC12056728</pmcid><funding_grant_id>13-419 RG/PHA/AS_CUNESCO FR: 3240279216</funding_grant_id><pubmed_authors>Ullah A</pubmed_authors><pubmed_authors>Al-Harrasi A</pubmed_authors><pubmed_authors>Ali MI</pubmed_authors><pubmed_authors>Ullah S</pubmed_authors><pubmed_authors>Mehreen S</pubmed_authors><pubmed_authors>Anwar MU</pubmed_authors><pubmed_authors>Khan A</pubmed_authors><pubmed_authors>Hussain J</pubmed_authors><pubmed_authors>Zia M</pubmed_authors><pubmed_authors>Naseer MM</pubmed_authors><pubmed_authors>Muntha ST</pubmed_authors></additional><is_claimable>false</is_claimable><name>Synthesis, structural insights and bio-evaluation of &amp;lt;i&amp;gt;N&amp;lt;/i&amp;gt;-phenoxyethylisatin hydrazones as potent α-glucosidase inhibitors.</name><description>Effective α-glucosidase inhibitors are vital for managing type 2 diabetes, emphasizing the need for novel and potent compounds. A series of novel &lt;i>N&lt;/i>-phenoxyethylisatin hydrazones 1(a-l) have been synthesized and characterized by their spectral data, and in the case of 1l by its single crystal X-ray analysis. All the synthesized compounds were &lt;i>in vitro&lt;/i> evaluated for their inhibition potential against the α-glucosidase enzyme. Interestingly, most of these compounds exhibited significant inhibitory activity against the α-glucosidase enzyme, with IC&lt;sub>50&lt;/sub> values ranging from 3.64 ± 0.13 to 94.89 ± 0.64 μM compared to the standard drug, acarbose (IC&lt;sub>50&lt;/sub> = 873.34 ± 1.67 μM). The compound 1e was found to be the most active compound of the series having an IC&lt;sub>50&lt;/s</description><dates><release>2025-01-01T00:00:00Z</release><publication>2025 May</publication><modification>2026-06-01T05:55:56.822Z</modification><creation>2026-04-08T09:46:01.543Z</creation></dates><accession>S-EPMC12056728</accession><cross_references><pubmed>40337235</pubmed><doi>10.1039/d5ra00770d</doi></cross_references></HashMap>